Hypolipidemic arylthioalkanoic acids

Abstract
A series of arylthioalkanoic acids related to probucol was studied for hypolipidemic activity. Homologation of the alkyl side chain led to marked changes in the serum cholesterol and serum triglyceride lowering activity in rats with the best combination of properties appearing in compound 7, 2-[(3,5-di-tert-butyl-4-hydroxyphenyl)thio]hexanoic acid. Modification of the ring substitution failed to imporve the activity despite the empirical observation that lipophilic substitution was necessary. Removal of the phenolic hydroxyl produced a compound with properties similar to 7 but of somewhat lower activity. Replacement of the sulfur by oxygen increased the toxicity of the series. Resolution of racemic 7 did not change the activity of the compound. The LD50 in mice of 7 was between 5000-10,000 mg/kg, and compound 7 was submitted for human clinical evaluation.

This publication has 1 reference indexed in Scilit: